The book is currently out of stock
More about the book
Duchenne muscular dystrophy, a rare genetic disorder, currently has only one authorized treatment: ataluren. However, its efficacy, financing, and availability vary across Europe and Spain, where it is not covered by public health systems, leaving affected children without access to treatment. This situation has sparked a significant debate encompassing ethical issues of equity and justice, alongside legal principles concerning the protection of minors, highlighting the complexities surrounding healthcare access for rare diseases.
Book purchase
DUCHENNE DISEASE: COMPLEXITIES IN THE USE OF ATALUREN IN SPAIN., Pilar Pacheco López, María Antonia Meroño Saura, Miguel Ángel Carvajal Sánchez
- Language
- Released
- 2022
- product-detail.submit-box.info.binding
- (Paperback)
We’ll email you as soon as we track it down.
Payment methods
No one has rated yet.